The year in cardiovascular medicine 2021: digital health and innovation

PE Vardas, FW Asselbergs, M van Smeden… - European heart …, 2022 - academic.oup.com
This article presents some of the most important developments in the field of digital medicine
that have appeared over the last 12 months and are related to cardiovascular medicine. The …

Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers

G Joy, J Artico, H Kurdi, A Seraphim, C Lau… - Cardiovascular …, 2021 - jacc.org
Objectives The purpose of this study was to detect cardiovascular changes after mild severe
acute respiratory syndrome-coronavirus-2 infection. Background Concern exists that mild …

Adopting artificial intelligence in cardiovascular medicine: A scoping review

H Makimoto, T Kohro - Hypertension Research, 2024 - nature.com
Recent years have witnessed significant transformations in cardiovascular medicine, driven
by the rapid evolution of artificial intelligence (AI). This scoping review was conducted to …

High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning

G Duffy, PP Cheng, N Yuan, B He, AC Kwan… - JAMA …, 2022 - jamanetwork.com
Importance Early detection and characterization of increased left ventricular (LV) wall
thickness can markedly impact patient care but is limited by under-recognition of …

Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study

J Artico, H Shiwani, JC Moon, M Gorecka, GP McCann… - Circulation, 2023 - Am Heart Assoc
Background: Acute myocardial injury in hospitalized patients with coronavirus disease 2019
(COVID-19) has a poor prognosis. Its associations and pathogenesis are unclear. Our aim …

Application of machine learning for cardiovascular disease risk prediction

S Dalal, P Goel, EM Onyema, A Alharbi… - Computational …, 2023 - Wiley Online Library
Cardiovascular diseases (CVDs) are a common cause of heart failure globally. The need to
explore possible ways to tackle the disease necessitated this study. The study designed a …

Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy

A de Marvao, KA McGurk, SL Zheng, M Thanaj… - Journal of the American …, 2021 - jacc.org
Background Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-
encoding genes, but little is known about the clinical significance of these variants in the …

Microstructural and microvascular phenotype of sarcomere mutation carriers and overt hypertrophic cardiomyopathy

G Joy, CI Kelly, M Webber, I Pierce, I Teh, L McGrath… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: In hypertrophic cardiomyopathy (HCM), myocyte disarray and
microvascular disease (MVD) have been implicated in adverse events, and recent evidence …

Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging

YR Wang, K Yang, Y Wen, P Wang, Y Hu, Y Lai… - Nature Medicine, 2024 - nature.com
Cardiac magnetic resonance imaging (CMR) is the gold standard for cardiac function
assessment and plays a crucial role in diagnosing cardiovascular disease (CVD). However …

The role of artificial intelligence in cardiovascular magnetic resonance imaging

AA Aromiwura, JL Cavalcante, RY Kwong… - Progress in …, 2024 - Elsevier
Cardiovascular magnetic resonance (CMR) imaging is the gold standard test for myocardial
tissue characterization and chamber volumetric and functional evaluation. However, manual …